Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal Cancer. Issue 2 (8th March 2021)

• Record Type: Journal Article
• Authors: Jenkins, Mark A; Buchanan, Daniel D; Lai, John; Makalic, Enes; Dite, Gillian S; Win, Aung K; Clendenning, Mark; Winship, Ingrid M; Hayes, Richard B; Huyghe, Jeroen R; Peters, Ulrike; Gallinger, Steven; Marchand, Loïc Le; Figueiredo, Jane C; Pai, Rish K; Newcomb, Polly A; Church, James M; Casey, Graham; Hopper, John L
• Is Part Of: JNCI cancer spectrum. Volume 5:Issue 2(2021)
• Publication Date: 2021-03-08
• DOI: 10.1093/jncics/pkab022
• Languages: English
• ISSNs: 2515-5091

Abstract

Abstract: It was not known whether the polygenic risk scores (PRSs) that predict colorectal cancer could predict colorectal cancer for people with inherited pathogenic variants in DNA mismatch repair genes—people with Lynch syndrome. We tested a PRS comprising 107 established single-nucleotide polymorphisms associated with colorectal cancer in European populations for 826 European-descent carriers of pathogenic variants in DNA mismatch repair genes (293 MLH1, 314 MSH2, 126 MSH6, 71 PMS2, and 22 EPCAM ) from the Colon Cancer Family Registry, of whom 504 had colorectal cancer. There was no evidence of an association between the PRS and colorectal cancer risk, irrespective of which DNA mismatch repair gene was mutated, or sex (all 2-sided P > .05). The hazard ratio per standard deviation of the PRS for colorectal cancer was 0.97 (95% confidence interval = 0.88 to 1.06; 2-sided P = .51). Whereas PRSs are predictive of colorectal cancer in the general population, they do not predict Lynch syndrome colorectal cancer.